FDA Approves Gilead Sciences' Remdesivir Treatment for Covid-19
October 22 2020 - 5:01PM
Dow Jones News
By Allison Prang
The U.S. Food and Drug Administration approved Gilead Sciences
Inc.'s remdesivir treatment -- known as Veklury-- for people that
need to be hospitalized from Covid-19, the company said
Thursday.
The drug had been approved by the regulator for emergency use to
treat people who got the virus. In one trial of the treatment, it
was shown to improve recovery time by five days when looking at the
total study population, according to Gilead.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
October 22, 2020 16:46 ET (20:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024
